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T CELL INTEGRIN DEPENDENT, MKK3/p38 MAPK-MEDIATED STABILIZATION OF LABILE CYTOKINE 
mRNAs. 
Scott D. DeGregorio Vinod S. Ramgolam, Sharmila Subaran, Mark Collinge, Hongbo Chi, Richard A. Flavell, and 
Jeffrey R. Bender.  Section of Vascular Biology and Transplantation, Yale University School of Medicine, New 
Haven, CT. 
 
The goal of this project is to elucidate the signaling pathway involved in the T cell integrin lymphocyte function-
associated antigen 1 (LFA-1) engagement-mediated, HuR nuclear-to-cytoplasmic translocation and subsequent mRNA 
stabilization. 
 To examine the pathway transducing LFA-1 engagement-mediated mRNA stabilization, we employed 
quantitative, real time RT-PCR in the presence of a transcriptional inhibitor to examine the half-life of interferon gamma 
(IFN-γ) mRNA, a labile cytokine transcript.  We used immunofluorescence to observe the nuclear-to-cytoplasmic 
tranlocation of HuR, an mRNA-binding and –stabilizing protein.  We also used Western blot analysis to analyze the 
activity levels of specific mitogen activated protein kinases (MAPKs) upon LFA-1 engagement.  These techniques were 
performed using murine splenocyte-derived T cells from wild type as well as transgenic mice lacking one or both copies of 
the MAPK kinase MKK3 gene.  They were also performed in the presence of MAPK pharmacologic inhibitors, RNA 
interference for HuR, and transfection vectors for constitutively active Rho-GTPases and MAPKs. 
 Our data show that, in murine wild type T cells, LFA-1 engagement by its ligand, intercellular adhesion 
molecule-1 (ICAM-1), causes both HuR translocation and an increased half-life of IFN-γ mRNA transcripts.  This mRNA 
stabilization is HuR-dependent: a decrease in HuR expression in T cells by RNA interference abrogates the LFA-1 
induced IFN-γ mRNA stabilization. 
 To examine the pathway responsible for LFA-1 engagement-mediated mRNA stabilization, we looked at 
MAPKs since T cell integrin engagement triggers mitogenesis.  LFA-1 engagement activates both c-jun NH2 terminal 
protein kinase (JNK), and stress activated protein kinase (SAPK) (also known as the p38 MAPK).  Pharmacologic 
inhibition of JNK, however, causes no decrease in HuR translocation or IFN-γ mRNA stabilization upon T cell integrin 
engagement, while pharmacologic inhibition of p38 MAPK inhibits both events.  Interruption of the p38 MAPK pathway by 
using T cells lacking the p38 MAPK kinase MKK3 also causes a loss of HuR translocation and subsequent IFN-γ mRNA 
stabilization upon LFA-1 engagement.  Activation of the p38 MAPK pathway alone via a constitutively active p38 MAPK 
kinase MKK6, however, was not sufficient to obtain IFN-γ mRNA stabilization. 
 From these data, we conclude that T cells utilize LFA-1 engagement by ICAM-1 to modulate the stability of 
labile mRNA transcripts encoding proinflammatory cytokines.  Modulation of the RNA binding molecule HuR is required 
for this mRNA stabilization.  Furthermore, the MKK3/p38 MAPK pathway is necessary for LFA-1 engagement-mediated 
mRNA stabilization.  Activation of the p38 MAPK pathway alone, however, is not sufficient to generate the stabilization of 
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Introduction 
Leukocytes are specialized immune cells that continually migrate 
throughout the bloodstream, into peripheral tissues and peripheral lymphoid 
organs (1).  The functions of leukocytes can be divided into those subserving 
innate and adaptive immunity.  Innate immunity utilizes granulocytes and 
macrophages in a non-adaptive mechanism that provides a first line of defense 
against infection.  The adaptive immune system, on the other hand, is a delayed, 
pathogen-specific response mediated by lymphocytes.  The lymphocyte 
population has an enormous range of receptors that recognize various 
components of pathogens which are called antigens (2).  Lymphocytes are 
divided into B lymphocytes and T lymphocytes based on their receptors as well 
as their response to antigens.  B lymphocytes have antibodies (produced by the 
cells themselves) as their antigen receptor.  T lymphocytes, on the other hand, 
have a T cell receptor (TCR) that only recognizes peptide antigen bound to a 
major histocompatability complex (MHC) molecule on the cell membrane. 
Because T cells only recognize antigen bound to MHC proteins expressed 
on a cell’s plasma membrane, T cells require adhesive interactions with other 
cells for their functional activation.  In the thymus, T cells adhere to thymic 
epithelial cells for positive or negative selection where, depending on their 
reaction to specific MHC-bound proteins, they will receive mitogenic or apoptotic 
signals.  Upon entering the peripheral circulation, T cells will adhere to various 
antigen presenting cells (APCs) and receive mitogenic or lineage-specific 
differentiation signals depending on the environment within which the T cell binds 
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to the APC.  Once T cells have differentiated, strong adhesion with APCs is a 
requirement for activation of T cell effector functions (3). 
The T cell receptors for adhesive interactions are integrins, a ubiquitously 
expressed, highly conserved family of receptors involved in cell-extracellular 
matrix and cell-cell adhesion (1, 3, 4).  Integrins are heterodimeric proteins 
consisting of two subunits.  The ligands for the β2 subset (leukocyte-specific) 
integrin receptors are the intercellular adhesion molecules (ICAMs), a group of 
proteins within the immunoglobulin superfamily that are expressed by APCs as 
well as vascular endothelium (3, 4). 
Specifically, T cells express the αLβ2 intregrin lymphocyte function-
associated antigen 1 (LFA-1), which is composed of the subunits CD11a and 
CD18 (1).  Within the thymus, LFA-1 appears to be important in the process of T 
cell selection.  Research suggests that LFA-1 is required for the maturation of 
CD8+ T cells (4, 5).  LFA-1 also appears to play an integral role in T cell 
mitogenesis.  Simultaneous engagement of both the TCR and LFA-1 causes a 
more robust cell cycle transition from G1 to S phase than engagement of the 
TCR alone (6).  In the periphery, LFA-1 appears to play a key role in T cell 
differentiation, especially in the differentiation of naïve T cells into TH1 cells.  
Inhibition of naïve T cell LFA-1 interaction with ICAM-1 on the dendritic cell 
membrane leads to a predominance of TH2 cell development (7).  Furthermore, 
addition of ICAM-1 to anti-CD3/CD28-stimulated naïve T cells (anti-CD3/CD28 is 
used to stimulate the TCR) causes a Th1 phenotype which is blocked by the 
addition or anti-ICAM-1 or anti-LFA-1 blocking antibodies (8). 
 8
One of the important effector functions of differentiated T cells is the 
production of pro-inflammatory cytokines, which have tightly controlled 
expression profiles.  LFA-1 engagement in the presence of CD3-activated T cells 
causes an amplification of the steady state IFN-γ mRNA levels. Furthermore, 
IFN-γ is a labile transcript with a destabilizing AU-rich element (ARE) in its 3’ 
untranslated region (3’-UTR).  Measurement of IFN-γ mRNA half-life using a 
mRNA polymerase II inhibitor reveals a profound stabilization of the transcript 
when LFA-1 is engaged in CD3-stimulated T cells (3, 9).  Thus, LFA-1 
engagement leads to an increase in IFN-γ mRNA transcripts, as well as 
increased stability of those transcripts, within T cells (10). 
Another important effector function of differentiated T cells is migration of 
T cells across vascular endothelium.  T cell migration is essential to the 
pathogenesis of many inflammatory diseases, as well as to the ultimate 
localization of cells homing to a particular tissue or site of inflammation.  
Endothelial migration requires interaction between the T cell and the endothelial 
cell and its underlying basement membrane.  The process begins with a process 
called rolling, followed by arrest and firm adhesion.  Rolling is mediated by 
selectins, while firm adhesion requires the integrins LFA-1 and VLA-4, which bind 
ICAM-1 and VCAM-1, respectively, on the endothelial cell (1, 3).  Blockade of 
ICAM-1, VCAM-1, or both on endothelial cells prevents the formation of 
pseudopodia and lamellipodia by leukocytes, which are phenotypic indicators of 
cell arrest and are required for transendothelial migration (11). 
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To migrate across the endothelium successfully, T cells must be able to 
degrade proteins in the basement membrane and extracellular matrix (ECM).  
Matrix metalloproteinases (MMPs) are a family of endopeptidases used by T 
cells to break down ECM.  T cells constitutively express small quantities of 
MMPs, and engagement of the integrin VLA-4 can both increase the expression 
of MMPs by T cells as well as increase enzyme activity (12).  While MMPs are 
vital to T cell migration through the basement membrane and ECM, the 
plasminogen activation system plays a crucial role in cell migration into 
surrounding tissue.  Plasmin is a serine protease that breaks down ECM proteins 
outside of the endothelium.  It circulates through the body in the inactive, pro-
form plasminogen and is converted to plasmin by urokinase plasminogen 
activator (uPA).  uPA binding to its receptor, uPAR, is required for its activation.  
uPAR is inducibly expressed by T cells.  Engagement of LFA-1 or VLA-4 in CD3-
stimulated T cells potently induces T cell expression of uPAR (13).  Like IFN-γ 
mRNA, the uPAR transcript contains a destabilizing ARE in its 3’-UTR.  
Furthermore, CD3/LFA-1 co-stimulation-induced T cell transmigration across a 
matrigel-coated filter is enhanced by the addition of plasminogen and inhibited by 
amiloride (uPAR inhibitor) as well as by an antibody that blocks the uPA binding 
site on uPAR (3).  Thus, induced T cell uPAR is functional to promote migration. 
T cell integrin engagement is required for many of the T cell’s most 
important functions, such as thymic selection and mitogenesis, T cell 
differentiation, cytokine expression, and migration across vascular endothelium 
into surrounding tissues.  Data suggest that integrin engagement regulates T cell 
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post-transcriptional events, which in turn affect T cell function.  As previously 
mentioned, many of the mRNA transcripts affected by integrin engagement 
contain a destabilizing ARE in the transcript’s 3’-UTR.  These transcripts include 
cyclin A and cyclin B1 (responsible for thymic mitogenesis) in addition to IFN-γ 
and uPAR (14).  LFA-1 engagement in CD3-stimulated T cells causes a 
stabilization of each of these transcripts.  To determine if the ARE in the 3’-UTR 
is important to LFA-1-mediated mRNA stabilization, the uPAR 3’-UTR was 
cloned into an otherwise stabile rabbit β-globin transcript.  When the construct 
was expressed in T cells, the 3’-UTR caused a destabilization of the rabbit β-
globin transcript, which was reversed by mutagenesis of the uPAR ARE within 
the 3’-UTR.  Furthermore, LFA-1 engagement of the T cell containing the 
construct conferred stability to the rabbit β-globin transcript (9).  These findings 
confirm that LFA-1 engagement on T cells generates at least one signal that 
inhibits mRNA instability caused by an ARE in the transcript’s 3’-UTR. 
One possible candidate for the mRNA stabilization signal signal generated 
by LFA-1 engagement is the molecule HuR.  HuR, which is a member of the 
embryonic lethal, abnormal vision (ELAV) family of proteins, has been shown to 
bind AREs within the 3’-UTR of mRNA transcripts and have a stabilizing effect on 
these transcripts (15, 16).  In a resting T cell, HuR resides in the nucleus.  LFA-1 
engagement causes a nuclear-to-cytoplasmic translocation of HuR, which is 
required for stabilization of mRNA transcripts containing AREs (9, 17, 18).  This 
mRNA stabilization facilitates enhanced expression of critical T cell gene 
products in response to integrin engagement. 
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The molecular signaling pathway responsible for transducing the signal 
between LFA-1 engagement and HuR nuclear-to-cytoplasmic translocation is 
unknown.  Previous work done in the lab demonstrates that LFA-1 activates Vav-
1 in a PI-3 Kinase dependent manner.  Vav-1 is a guanine nucleotide exchange 
factor (GEF) for Rac-1 and Rac-2.  Rac-1 and Rac-2 are Rho-GTPases, 
implicated in MAPK signaling in T cells, which exist in a non-active, GDP-bound 
state.  Activation of Vav-1 causes Rac to exchange its GDP for GTP, activating 
Rac and thus its downstream effectors.  Both Vav and Rac activation are 
required for LFA-1-mediated mRNA stabilization (Ramgolam et al, in 
preparation).  The pathway distal to Rac-1/Rac-2 activation, however, remains 
unknown.  Since two of the proteins stabilized by LFA-1 engagement are 
responsible for mitogenesis within T cells, the most likely candidates for the 
signaling pathway include the mitogen-activated protein kinases (MAPKs).  In T 
cells, there are three major MAPK pathways: the extracellular signal regulated 
protein kinase (ERK) pathway, the c-jun NH2 terminal protein kinase (JNK) 
pathway, and the stress activated protein kinase (SAPK) pathway (also known as 
the p38 MAPK pathway) (19).  Of these three pathways, the JNK pathway and 
the p38 MAPK pathway are the most likely candidates.  In the thymus, the MAPK 
kinase MKK6, which activates p38 MAPK, is responsible for T cell selection.  
Specifically, it is responsible for the deletion of CD4+CD8+ T cells within the 
thymus (20).  The JNK and p38 pathways are both integral in T cell 
differentiation.  Activation of p38 in naïve T cells causes the release of IL-12, 
while both p38 and the JNK isoform JNK2 stimulate differentiation of naïve T 
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cells into Th1 cells (21, 22).  Furthermore, JNK1 inhibits Th2 differentiation of 
naïve T cells, promoting a Th1 phenotype (23).  Thus, the JNK and p38 MAPK 
pathways both promote Th1 differentiation of naïve T cells, which induces the 
expression of IFN-γ and TNF-α, two cytokines whose mRNA transcripts contain 
AREs in their 3’-UTRs. 
There is also evidence linking the p38 MAPK pathway to HuR nuclear-to-
cytoplasm translocation and mRNA stabilization directly (24, 25).  These findings 
were confirmed in a paper by Han et al which established that the Rac-
1/MKK3/p38MAPK/MK2 pathway is involved in ARE-mediated mRNA 
stabilization in breast cancer cells (26).  This study is important because it not 
only confirms the possible role of p38 MAPK in HuR-mediated mRNA 
stabilization, it also established the Rho-GTPase Rac-1 as being upstream of 
p38 MAPK, as well as MAPK-activated protein kinase 2 (MK2) as being a 
downstream effector of p38.  MKK3, which is directly downstream of Rac-1 in this 
study, is the MAPK kinase that activates p38 MAPK within T cells outside of the 
thymus (27).  Another study linked MK2 to HuR mediated mRNA stabilization of 
uPAR transcripts, providing indirect evidence that LFA-1 engagement may 
mediate HuR translocation and subsequent mRNA stabilization through the p38 
MAPK pathway (17).  However, no study up to this point has directly investigated 
and defined the intermediaries between LFA-1 and HuR. 
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Statement of Purpose 
 The goal of this project is to elucidate the signaling pathway involved in T 
cell LFA-1 engagement-mediated HuR nuclear-to-cytoplasmic translocation and 
subsequent mRNA stabilization.  We hypothesize that the p38 MAPK pathway, 
acting through Rac and MKK3, is the pathway linking LFA-1 with HuR 
translocation and Th1 cell effector function. 
 
Methods 
(All work was performed by Scott D. DeGregorio unless stated otherwise). 
Antibodies and Reagents 
The following antibodies (Ab) were used: anti-p38MAPK, phospho-
p38MAPK, JNK Abs were purchased from Cell Signaling (Beverly, MA), anti-
phospho-c-Jun, anti-GFP mouse mAbs were purchased from Santa Cruz (CA).  
Anti-HuR (3A2) mouse monoclonal Ab was a kind gift from Dr. Joan Steitz (Yale 
University, New Haven, CT).  Murine anti-CD3 FITC conjugated Abs and NK1.1 
PE were purchased from BD Biosciences (San Jose, CA).  Phorbol Myristate 
Acetate (PMA), poly-L-lysine, 5.6-dichlorobenzimidazole (DRB), and DAPI were 
purchased from Sigma (St. Louis, MO).  The pharmacological inhibitors 
SB203580 and SP600125 were purchased from Calbiochem (San Diego, CA).  
The murine soluble ICAM-1 producing cell line, NS-1, was a generous gift from 
Dr. F. Takei (University of British Columbia, Vancouver, Canada) and murine 
soluble ICAM-1 was purified as described (Welder et al. 1993).  The anti-murine 
ICAM-1 mAb YN1/1.74 has been described (Takei et al. 1985).  
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Cell preparation, Cell culture, and Transient Transfection 
C57BL/6 mice were purchased from Jackson Laboratory (Bar Harbor, 
ME). MKK3-/- deficient mice were a gift from Dr. R. Flavell and have been 
described before (28).   Murine spleens were harvested from wild type C57BL/6, 
C57BL/6-backcrossed MKK3+/-, or C57BL/6-backcrossed MKK3-/- mice.  Murine 
splenic T cells were isolated by negative selection as described before (29).  
Briefly, murine spleens were homogenized, centrifuged, and the supernatant 
discarded.  The cell pellet was rinsed with sterile water to lyse red blood cells.  
The cells then passed over a nylon wool column to remove B cells and 
macrophages.  NK cells were removed using anti-NK1.1 antibodies conjugated to 
magnetic beads.  T cells were then stained with murine anti-CD3 FITC-
conjugated Abs and anti-NK1.1 PE-conjugated Abs, of which greater than 95% 
were CD3+ positive (Figure 1). Jurkat cells were obtained from the American 
Type Culture Collection and maintained in RPMI-1640 medium (Gibco, Grand 
Island, NY) supplemented with 10% fetal bovine serum, 2 mM glutamine, and 
100 U/ml each of penicillin G and streptomycin.  
 
Plasmids and siRNA sequence 
The Rac-2 wild type and constitutively active Rac-2 constructs were a gift 
from Dr. Honghbo Chi (Yale University, CT, USA).  The pGEF-BOS-CAT and 
pBBB-3’UPAR were cloned in our laboratory, by Vinod Ramgolam, as previously 
described (9).  The constitutively active MKK62E constuct was a generous gift 
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from Dr. Holtmann (Medical School of Hanover, Germany).  Jurkat cells were 
transfected by electroporation.  Briefly, cells were washed twice with Optimem 
(Invitrogen) and resuspended in Optimem at a concentration of 50 x 106 cells/ml.  
Approximately, 20 x 106 cells (400 μl) were transferred in a 0.4 cm 
electroporation cuvette (Bio-Rad, CA) with 25 μg of each pDNA (total 75 μg of 
pDNA/20 x 106 cells).  Transfections were conducted at 960 μF/250V (Gene 
Pulser, Bio-Rad, CA).  Cells were cultured overnight in 10 ml media containing 
0.5% FBS and 2 mM L-glutamine.  Transfection was confirmed by SDS-PAGE of 
lysates from transfected cells, or by exogenous mRNA expression by quantitative 
real-time PCR. 
HuR siRNA primers were designed by Mark Collinge and synthesized by 
the Keck Biotechnology resource facility at Yale.  The duplex used to specifically 
target HuR was: AAGAGUGAAGGAGUUGAAAU, (HuRsiRNA) corresponding to 
nucleotides 1187-1205 of human HuR mRNA and is located in the 3’UTR: The 
scrambled siRNA sequence was AGCCAAUUCAUCAGCAAUGG (SCsiRNA). 
The control duplex was a scrambled version of HuRsiRNA. The duplexes 
HuRsiRNA and SCsiRNA were prepared by Qiagen (Valencia, CA). 
 
Immunofluorescence 
Glass coverslips were coated with 2.5 μg/ml murine sICAM-1 in PBS or 20 
μg/ml poly-L-lysine at 4oC with in H2O overnight at 4oC.  Cells were pre-adhered 
to poly-L-lysine coated cover slips.  LFA-1 conformational activation was 
achieved by treatment with LFA-1 activation buffer (100 mM Tris.HCl, pH 7.5, 
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0.9% NaCl, 2 mM MnCl2, 2 mM MgCl, D-glucose 5mM 1.5% BSA).  Mn2+ binds to 
the metal ion-dependent adhesion site (MIDAS) on the LFA-1α chain and 
promotes an allosteric transition to a high affinity state for its ligand(s), thereby 
inducing cell adhesion without cell activation.  Cells were plated for 60 minutes 
on ICAM-1-coated cover slips or cells pre-adhered to poly-L-lysine were also 
treated with LFA-1 activation buffer for 60 minutes.  Cells were fixed with 4% 
paraformaldehyde and permeabilized with 0.1% Triton X-100.  Cells were 
blocked with 5% goat serum overnight at 4oC, followed by staining with 5 μg/ml 
anti-HuR overnight at 4oC, followed by cyanine 3-conjugated goat anti-mouse 
antibody (dilution 1:1000) immunostaining.  Cells were co-stained with 0.005% 
DAPI for nuclear definition. 
 
p38MAPK and c-Jun phosphorylation (Performed by Vinod Ramgolam, 
analyzed by Scott DeGregorio) 
Murine T cells (107cells/ml), treated with LFA-1 activation buffer, were pre-
adhered to poly-L-lysine-coated dishes or plated on 2.5 μg/ml sICAM-1 coated 
dishes for the indicated time points.  Freshly isolated murine T cells were 
stimulated as described above, then lysed with 20 mM Tris.HCl, pH 7.5, 150 mM 
NaCl, 5 mM EDTA, 5mM Na4P2O7, 1 mM Na3VO4, 20 mM NaH2PO4, 3mM β-
glycerophosphate, 10mM NaF. Jurkat Cells were transfected as described above 
and stimulated with 10% serum for 4 hrs. p38MAPK and c-Jun phosphorylation 
was analyzed by SDS-PAGE and immunoblotted with anti-phospho-p38MAPK, 
anti-p38MAPK, phospho-c-Jun and JNK abs and probed with a secondary goat 
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anti- mouse or rabbit IRDye conjugated, species-specific antibody (Rockland, 
Gilbertsville, PA) and visualized using an Odyssey Imaging Systems (LI-COR, 
Lincoln, NE). 
 
mRNA stabilization experiments and Quantitative Real Time-PCR  
Petri dishes were coated with either 2.5 μg/ml murine ICAM-1 in PBS or 
20 μg/ml poly-L-lysine in H2O overnight at 4oC.  Murine T cells (107/sample), 
stimulated with 2 ηg/ml phorbol 12-myristate 12-acetate (PMA), were pre-
adhered to poly-L-lysine-coated dishes, or plated on ICAM-1-coated dishes. In 
the case of JNK inhibition with SP600125, murine T cells were pre-treated for 60 
minutes before stimulation with 2 ηg/ml PMA.  mRNA synthesis was inhibited 
after 3 hrs of incubation by the addition of 1.0 µM of the RNA polymerase II-
specific inhibitor 5,6-dichloro-1-β-D-ribobenzimidazole (DRB), after which cells 
were lysed for RNA isolation.  Transfected Jurkat cells were serum-stimulated for 
4 hours to allow for rabbit β-globin gene transcription with 10% serum, after 
which cell samples were collected every hour up to 4 hours.  In the case of 
p38MAPK or c-Jun phosphorylation inhibition, cells were treated with 1 μM 
SB203850 and 10 μM SP600125, respectively.  RNA was isolated with the 
Qiagen RNeasy kit (Qiagen, Valencia, CA).  cDNA was prepared from 1 μg of 
RNA with iScript (Bio-Rad, CA) and analyzed by quantitative real-time RT-PCR 
using the Opticon 2 System (MJ Research, Waltham, MA).  SYBR Green PCR kit 
was purchased from Qiagen (Valencia, CA).  Murine IFN-γ mRNA levels were 
normalized against Cyclophilin-α, with expression relative to time 0 when 
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transcription was inhibited. The sequence of the primers used were as followed: 
Cyclophilin-α Forward primers: ATTATTCCAGGATTCATGTGCCAG, Cyclophilin-
α Reverse primers: TGAAGGGGAATGAGGAAAATATGG; IFN-γ Forward 
primers: AGCGGCTGACTGAACTCAGATTGTAG; IFN-γ Reverse primers: 
GTCACAGTTTTCAGCTGTATAGGG.  Rabbit β-globin mRNA were normalized 
against CAT, with expression relative to time 0.  The sequence of the primers 
were as follows:  CAT Forward primers: GGATAGTTTCACCCTTGTT; CAT 
Reverse primers: GATTGGCTGAGACGAAAAAC; Rabbit β-globin Forward 
primers: TGGTTGTCTACCCATGGACC; Rabbit β-globin Reverse primers: 
ATCCACGTGCAGCTTGTCAC.  All primers were synthesized by the Keck 
Biotechnology resource facility at Yale. 
 
Results 
LFA-1 induces mRNA stabilization 
T cell LFA-1 engagement is partially responsible for effector T cell 
function, including pro-inflammatory cytokine production.  Previous studies that 
examined LFA-1 engagement-mediated mRNA stabilization used LFA-1 
activating antibodies rather than its natural ligand, ICAM-1.  Our first goal was to 
show that LFA-1 engagement by ICAM-1 leads to stabilization of mRNA 
transcripts.   Murine T cells were stimulated with the phorbol ester PMA 
(replacing CD3 engagement as the T cell gene activator) or PMA with ICAM.  
After 3 hours of stimulation, transcription was arrested.  To assess the half life of 
the T cell transcripts present at the time of transcriptional arrest, cells were lysed 
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at 0, 15, 30, and 45 minutes after arrest.  mRNA levels were evaluated at each 
time point by real time RT-PCR.  The transcript level for the pro-inflammatory 
cytokine IFN-γ was compared to the stable, housekeeping mRNA encoding 
cyclophilin-α, at each time point.  The results are illustrated in Figure 2.  When 
cells are stimulated with PMA alone, less than 10% of the IFN-γ transcript is 
present in the cell 45 minutes after transcriptional arrest.  However, when T cell 
β2 integrin is engaged in addition to PMA recruitment, 60% of the IFN-γ transcript 
remains at 45 minutes after transcriptional arrest.  These results suggest that 
LFA-1 engagement by ICAM-1 leads to stabilization of the mRNA transcript 
encoding the pro-inflammatory/immune cytokine IFN-γ. 
 
LFA-1 engagement induces HuR nuclear-to-cytoplasmic translocation 
IFN-γ mRNA transcripts contain destabilizing AREs in their 3’-UTRs.  
Since HuR is known to bind mRNA AREs and prevent degradation of those 
transcripts, and since LFA-1 engagement confers stability to IFN-γ transcripts, 
we hypothesize that LFA-1 stabilizes the IFN-γ transcripts through HuR.  While it 
has been demonstrated in human T cells that LFA-1 engagement causes HuR 
nuclear-to-cytoplasmic translocation and subsequent mRNA binding, no one has 
ever shown a link between LFA-1 engagement and HuR translocation in the 
murine system.  Therefore, we attempted to show that LFA-1 engagement 
causes HuR translocation in murine T cells.  T cells were plated on cover slips 
and treated with LFA-1 activation buffer alone, or LFA-1 activation buffer in the 
presence of ICAM-1, for up to one hour.  The LFA-1 activation buffer contains 
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MnCl2 which induces a conformational change in LFA-1, allowing it to bind ICAM-
1 more avidly.  HuR was stained with a fluorescent antibody and compared to 
DAPI, a fluorescent marker which stains the nucleus.  Each population of cells 
were stimulated for 15, 30, 45, and 60 minutes, then washed and fixed to a slide.  
In T cells stimulated with ICAM, HuR begins to translocate out of the nucleus as 
soon as 15 minutes after incubation with ICAM begins.  After 60 minutes of 
adhesion onto ICAM, all visible HuR has translocated out of the nucleus and into 
the T cell cytoplasm (Figure 3).  Incubation up to 60 minutes with the LFA-1 
activation buffer alone does not induce translocation of HuR (data not shown).  
We conclude that, in murine T cells, LFA-1 engagement causes HuR nuclear-to-
cytoplasmic translocation, where it binds to and stabilizes IFN-γ transcripts. 
 
HuR is required for Rac-mediated mRNA stabilization 
 We have shown that LFA-1 engagement causes both HuR 
translocation and mRNA stabilization.  Our next goal was to demonstrate directly 
that HuR is required for LFA-1-mediated mRNA stabilization.  Previous work in 
our lab demonstrates the role of the Rho-GTPases Rac-1 and Rac-2 in LFA-1 
engagement-mediated mRNA stabilization (Ramgolam et al, in preparation).  To 
address whether HuR is required for mRNA stabilization, HuR was “knocked 
down” via RNA interference in the presence of constitutively active Rac-1 and 
Rac-2 constructs.  RNA interference uses small (~21 nucleotide), double-
stranded RNA sequences, complementary to the transcript of interest, which bind 
to and cause the degradation of that particular mRNA.  RNA interference is much 
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more precise than antisense RNA (30).  After RNA interference of HuR, mRNA 
stabilization was assessed in the presence of constitutively active Rac constructs 
which are capable of inducing mRNA stabilization (Ramgolam et al, in 
preparation).  Unfortunately, due to the inherent inefficiency of T cell transfection, 
endogenous IFN-γ mRNA transcripts could not be quantitated to examine 
whether constitutive Rac/p38 activation causes mRNA stabilization.  Instead, we 
co-transfected an mRNA reporter construct as a readout for stabilization. 
The exogenous gene used for mRNA stabilization experiments is the 
rabbit β-globin gene attached to a serum-inducible promoter.  The rabbit β-globin 
gene encodes an extremely stable transcript: transfection into human Jurkat T 
cells followed by serum-induced transcription generates transcripts that show no 
degradation 400 minutes after transcription.  The rabbit β-globin gene becomes 
destabilized by fusing AREs into its 3’-UTR.  By exchanging the natural 3’-UTR of 
rabbit β-globin with the 3’-UTR of uPAR, the transcript degrades and is 
undetectable 400 minutes after transcription in Jurkat T cells (9).  Since 
stabilization of this destabilized rabbit β-globin transcript would presumably 
require HuR to bind the AREs and stabilize the transcript, this construct makes 
an ideal exogenous vector to analyze HuR-mediated mRNA stabilization. 
We transfected Jurkat T cells with the rabbit β-globin construct containing 
the uPAR 3’-UTR, as well as a serum-inducible chloramphenicol acyltransferase 
(CAT) gene which encodes the stable CAT mRNA and is used to normalize the 
transfection efficiency as well a mRNA half life.  Cells were then transfected with 
either a constitutively active Rac-1 or a constitutively active Rac-2 construct, both 
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of which have been shown to induce mRNA stabilization of rabbit β-globin 
transcripts containing the uPAR AREs (Ramgolam et al. in preparation).  Each 
population of cells then received either a 21 nucleotide RNA duplex 
complementary to HuR (HuR siRNA), or a scrambled sequence of the HuR 
siRNA (scRNA).  The results are shown in Figure 4.  Both the constitutively 
active Rac-1 and Rac-2 constructs induced mRNA stabilization of the 
destabilized β-globin construct in the presence of the scrambled RNA duplex.  
When HuR was knocked down by at least 80% of its original level, neither 
constitutively active Rac-1 nor Rac-2 were able to induce mRNA stabilization of 
the modified β-globin construct.  These results show that HuR is required for 
Rac-mediated mRNA stabilization.  Since Rac-1 and Rac-2 are downstream of 
LFA-1, this suggests that HuR is required for LFA-1 engagement-mediated 
mRNA stabilization. 
 
LFA-1 engagement activates both the p38 MAPK and JNK pathway 
 After demonstrating, within a murine system, that LFA-1 engagement 
results in HuR translocation and mRNA stabilization of transcripts encoding pro-
inflammatory cytokines, we sought to elucidate the molecules mediating this 
signal transduction pathway.  As stated in the introduction, the two most likely 
effector pathways are the p38 MAPK pathway and the JNK pathway.  Cells were 
stimulated with ICAM-1 in the presence of LFA-1 activation buffer.  After 
stimulation, the cells were lysed and the activity of p38 MAPK and JNK were 
quantitated using monoclonal antibodies (it is convention to quantitate p38 
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activity with antibodies against phosphorylated p38 MAPK, while quantitating 
JNK activity with antibodies against phosphorylated c-jun, the active form of the 
JNK substrate).  After incubation of murine T cells with ICAM, p38 MAPK and 
JNK activity increased twelve-fold and 6.5-fold, respectively, when normalized to 
the total level of the respective proteins (Figure 5).  These results suggest that 
LFA-1 engagement activates both the p38 MAPK pathway and the JNK pathway. 
 
The JNK pathway does not play a role in LFA-1 mediated mRNA 
stabilization 
 Since LFA-1 engagement activates both the p38 MAPK and JNK 
pathways, it is possible that p38 MAPK, JNK, both, or neither mediate HuR 
translocation and subsequent mRNA stabilization.  To analyze whether JNK is 
necessary for LFA-1 mediated mRNA stabilization, we used the JNK-specific 
pharmacologic inhibitor SP600125 (31).  SP600125 competitively blocks the ATP 
binding site on JNK, inhibiting JNK’s ability to phosphorylate c-jun.  Using a 
concentration of 10 μM SP600125, we were able to inhibit JNK activity without 
inhibiting other MAP kinases, such as p38 MAPK (Figure 6a, data not shown).  
We then examined the effect of JNK inhibition on mRNA levels in T cells upon 
LFA-1 engagement.  Cells were stimulated with PMA, PMA and ICAM, or PMA 
and ICAM in the presence of SP600125.  After stimulation, the cells were lysed 
and their mRNA quantitated (Figure 6B).  T cells stimulated with PMA and ICAM 
demonstrated a twelve-fold increase in IFN-γ mRNA levels when compared to 
PMA stimulation alone.  The addition of 10 μM SP600125 to the T cells prior to 
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PMA and ICAM stimulation did not significantly alter mRNA levels; these T cells 
exhibited a 10-fold increase in IFN-γ mRNA levels compared to PMA stimulation.  
Since the major role of ICAM-1 stimulated LFA-1 engagement is to stabilize labile 
transcripts in this system, these results suggest that JNK is not required in LFA-1 
mediated modulation of mRNA levels.  However, this does not separate the LFA-
1 effect on transcriptional vs. post-transcriptional modulation of mRNA levels.  To 
distinguish this, we stimulated T cells with PMA, PMA/ICAM, and 
PMA/ICAM/SP600125.  After stimulation, we arrested transcription and 
quantitated IFN-γ mRNA levels at various timepoints folowing transcriptional 
arrest.  The addition of SP600125 did not abrogate the LFA-1 mediated mRNA 
stabilization 60 minutes after transcriptional arrest (Figure 6C).  These results 
support that JNK is not required for LFA-1 mediated mRNA stabilization. 
 
The JNK pathway does not play a role in LFA-1 mediated HuR translocation 
 Although JNK is not required for T cell integrin engagement-mediated 
mRNA stabilization, it is conceivable that JNK causes HuR translocation 
independent of HuR-mediated mRNA stabilization (and raising the possibility that 
LFA-1 mediated mRNA stabilization can also occur independently of HuR).  To 
examine this possibility, we observed HuR translocation in T cells in the 
presence of SP600125.  Stimulation of T cells with LFA-1 activation buffer and 
ICAM in the presence of 10 μM SP600125 has no effect on HuR translocation 
(Figure 7).  Indeed, doubling the dose of SP600125 to 20 μM did not abrogate 
the HuR translocation caused by LFA-1 engagement.  After 1 hour of stimulation, 
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all visible HuR is in the cytoplasm in the presence of the JNK inhibitor.  
Therefore, JNK appears to be required for neither LFA-1 mediated mRNA 
stabilization nor LFA-1 mediated HuR translocation. 
 
p38 MAPK is required for LFA-1 mediated mRNA stabilization 
 After establishing that JNK is not involved in LFA-1 mediated HuR 
translocation and subsequent mRNA stabilization, we examined whether p38 
MAPK is involved using the p38-specific pharmacologic inhibitor SB203580 (32).  
Like SP600125, SB203580 competitively blocks the ATP binding site of p38 
MAPK, inhibiting the enzyme’s ability to phosphorylate its substrates.  A 
concentration of 1 μM of SB203580 reduced p38 MAPK activity to baseline levels 
without inhibiting other MAP kinases (Figure 8A, data not shown).  We analyzed 
the effect of inhibiting p38 MAPK on LFA-1 modulation of mRNA levels.  As in 
previous experiments, stimulation with PMA and ICAM causes a twelve-fold 
increase in IFN-γ levels when compared to PMA stimulation alone.  Stimulating T 
cells in the presence of 1 μM SB203580, however, reduces IFN-γ levels to their 
baseline value (Figure 8B).  This demonstrates that p38 MAPK is required for 
LFA-1 mediated modulation of IFN-γ mRNA levels. 
 As previously stated, the experiment does not separate transcriptional and 
post-transcriptional events.  To examine whether p38 MAPK is required for LFA-
1 mediated mRNA stabilization, T cells were transcriptionally arrested after 
stimulation with PMA and ICAM in the presence of SB203580.  Quantitation of 
IFN-γ mRNA levels after transcriptional arrest shows that the addition of the p38 
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MAPK inhibitor causes a loss of mRNA stabilization upon LFA-1 engagement by 
ICAM.  Interestingly, IFN-γ mRNA levels in T cells stimulated with 
PMA/ICAM/SB203580 drop below those in T cells stimulated with PMA alone 
(this result is evident in repeated experiments, although statistical significance 
was not reached).  Together, these data demonstrate that p38 MAPK is required 
for LFA-1 engagement-mediated mRNA stabilization. 
 
MKK3 gene-deleted T cells demonstrate loss of p38 MAPK activity 
 We have pharmacologic evidence that the p38 MAPK pathway is required 
for LFA-1 engagement mediated mRNA stabilization.  Pharmacologic models are 
imprecise, however, given the inherent lack of specificity of pharmacologic 
inhibitors.  We therefore investigated the p38 MAPK pathway in a more precise, 
gene-deleted mouse system.  We received MKK3 gene deleted mice as a kind 
gift from Dr. Richard Flavell.  (as stated, MKK3 is the MAPK kinase which 
activates p38 MAPK in peripheral T cells (27).  Phenotypically, these mice 
appear normal, albeit smaller in overall size and with smaller spleens than their 
C57BL/6 wild type counterparts.  We bred MKK3 knockout (MKK3-/-) mice 
(backcrossed into the C57BL/6 strain) with wild type (MKK3+/+) C57BL/6 mice to 
generate heterozygous MKK3 (MKK3+/-) mice. 
 To confirm that the MKK3-/- mice actually have a deficiency in the p38 
MAPK signaling pathway, we isolated T cells from MKK3+/+, MKK3+/-, and MKK3-/- 
mice.  We activated the T cells with LFA-1 activation buffer and ICAM and 
analyzed p38 MAPK activity by Western blot.  Each population of T cells also had 
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an unstimulated control group against which p38 MAPK activity was normalized 
(Figure 9A).  The MKK3+/- had a 50% reduction in p38 MAPK activity upon LFA-1 
engagement when compared to MKK3+/+ T cells, and the MKK3-/- cells had a 
75% reduction in p38 MAPK activity when compared to the wild type cells.  In 
contrast, upon LFA-1 engagement, there is no correlation between JNK activity 
and the number of wild-type MKK3 alleles in T cells (Figure 9B).  These results 
indicate that MKK3 gene-deleted mice do have a selective defect p38 MAPK 
pathway, with other MAPK signaling pathways intact. 
 
MKK3-/- T cells have reduced IFN-γ mRNA levels upon LFA-1 engagement 
Since pharmacologically inhibiting p38 MAPK causes a decrease in IFN-γ 
mRNA levels upon LFA-1 engagement, we hypothesized that knocking out MKK3 
would also cause a reduction in IFN-γ levels upon T cell integrin engagement, 
although it is possible that multiple upstream kinases can co-activate p38 upon 
LFA-1 engagement.  There are at least 2 known MAPK kinases that activate p38 
MAPK (MKK3 and MKK6), and it is possible that MKK6, or some other currently 
unknown MAPK kinase, activates p38 MAPK and causes the HuR translocation 
and subsequent mRNA stabilization independent of MKK3.  To examine whether 
MKK3 is, in fact, the MAPK kinase responsible for LFA-1 mediated mRNA 
stabilization via p38 MAPK, we isolated MKK3+/+, MKK3+/-, and MKK3-/- T cells 
and analyzed  IFN-γ mRNA levels upon integrin engagement.  After stimulation 
with PMA and ICAM, MKK3+/- T cells contained 50% less IFN-γ mRNA than wild 
type T cells, while MKK3-/- T cells express 80% less IFN-γ than wild type T cells 
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(Figure 10).  These results suggest that MKK3 is required for IFN-γ mRNA 
modulation upon T cell integrin engagement. 
 
MKK3 KO T cells exhibit a loss of LFA-1 mediated mRNA stabilization 
 As stated previously, the prior experiment does not separate transcription 
vs. post-transcriptional modulation of mRNA levels.  To examine whether loss of 
the MKK3 gene causes instability of mRNA, T cells were stimulated as in 
previous experiments, mRNA transcription arrested, and IFN-γ mRNA levels 
quantitated at various timepoints after transcriptional arrest (Figure 11).  As 
expected, in MKK3+/+ mice, stimulation with PMA and ICAM increases the half life 
of IFN-γ mRNA levels, with 80% of transcripts present 45 minutes after 
transcriptional arrest.  If the MKK3 gene is completely knocked out, T cells 
largely lose the mRNA stabilization conferred by LFA-1 engagement: mRNA 
levels are 30% of their original value 45 minutes after transcriptional arrest.  
Surprisingly, the T cells with only one copy of the MKK3 gene exhibit complete 
stabilization of IFN-γ mRNA transcripts when compared to wild type T cells, 
despite reduced p38 MAPK activity compared to wild type T cells.  These results 
suggest that MKK3 is required for LFA-1 mediated mRNA stabilization through 
p38 MAPK.  Furthermore, MKK3 appears to act in a threshold-dependent 




MKK3 KO T cells exhibit a loss of LFA-1 mediated HuR nuclear-to-
cytoplasmic translocation 
Since MKK3-/- T cells demonstrate a loss of T cell integrin-mediated mRNA 
stabilization, we hypothesized that loss of MKK3 in T cells may also cause a loss 
of LFA-1 mediated HuR nuclear-to-cytoplasmic translocation.  We isolated 
MKK3+/+, MKK3+/-, and MKK3-/- T cells and stimulated them with ICAM in the 
presence of LFA-1 activation buffer.  LFA-1 activation buffer alone caused no 
HuR translocation in any of the three populations of T cells (data not shown).  
While stimulating wild type T cells with ICAM causes complete HuR 
translocation, stimulation of MKK3-/- T cells with ICAM causes no visible 
movement of HuR from the nucleus into the cytoplasm (Figure 12).  This 
confirms our suspicion that MKK3 is required for LFA-1 mediated HuR 
translocation and subsequent mRNA stabilization.  Furthermore, in MKK3+/- T 
cells, ICAM stimulation causes complete HuR translocation from the nucleus to 
the cytoplasm.  This mirrors the finding in the previous experiment that the 
MKK3+/- T cells phenotypically behave identically to MKK3+/+ T cells with respect 
to HuR translocation and subsequent mRNA stabilization despite having reduced 
p38 MAPK activity levels. 
 
Discussion 
 Our results support the hypothesis that the p38 MAPK pathway, acting 
through Rac-1/Rac-2 and the MAPK kinase MKK3, plays an integral role in 
peripheral T cell integrin engagement-mediated HuR translocation and 
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subsequent mRNA stabilization.  The pathway we propose from our data is 
illustrated in Figure 13.  Previous work in our laboratory demonstrates that LFA-1 
activation leads to Rac-1 and Rac-2 activation (Ramgolam et al., in preparation).  
The Rac proteins activate JNK, via MKK4 and MKK7, as well as p38 MAPK 
through MKK3 and MKK6.  JNK has been implicated in T cell differentiation (23) 
and, per our results, does not play a role in LFA-1 mediated mRNA stabilization.  
MKK3, acting through p38 MAPK, is required for T cell integrin-mediated mRNA 
stabilization.  Activation of p38 MAPK alone through MKK6, however, is not 
sufficient to induce mRNA stabilization (data not shown).  These data suggest 
that p38 is necessary but not sufficient for LFA-1 mediated mRNA stabilization.  
Therefore, signaling protein(s) separate from p38 MAPK must be involved in 
LFA-1 engagement-mediated mRNA stabilization.  These proteins have to be 
activated at or above the level of MKK3 within the signaling cascade.  One 
candidate class of proteins that may be involved in LFA-1 mediated mRNA 
stabilization is cytoskeletal proteins.  Integrin engagement on T cells causes a 
shift in proteins within the immunologic synapse that is cytoskeleton-dependent 
(33).  In addition, observation of T cells, upon LFA-1 engagement by ICAM, 
reveals striking morphologic changes by the T cell, whereupon it spreads along 
the ICAM and develops numerous lamellopodia.  Furthermore, experiments 
studying LFA-1 engagement in the presence of cytochalasin D, a pharmacologic 
inhibitor of actin polymerization, show that T cells require cytoskeletal 
rearrangement for MAP kinase activation (3), mitogenesis (34), and mRNA 
stabilization (Ramgolam, unpublished data) upon integrin engagement.  While 
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our lab has shown a loss of T cell integrin-mediated mRNA stabilization upon 
inhibition of actin polymerization, a loss of HuR translocation upon actin 
polymerization has not been evaluated.  However, in natural killer cells, LFA-1 
engagement was found to cause Vav-1 phosphorylation, which in turn was 
upstream of subsequent cytoskeletal reorganization (35).  Thus, it is possible that 
in T cells, Vav, Rac, and/or MKK3 induce cytoskeletal rearrangement in addition 
to p38 MAPK activation, and that both p38 MAPK activity and cytoskeletal 
rearrangement are required for LFA-1 mediated HuR translocation and 
subsequent mRNA stabilization. 
 An obvious question stems from our data.  What is the signal or signals 
that mediate p38 MAPK activation-induced HuR translocation?  One candidate 
protein is p38 MAPK-activated protein kinase 2 (MK2).  MK2 is a molecule that 
resides in the cytoplasm and, upon activation by p38 MAPK, binds to its 
chaperone, heat shock protein 27 (hsp-27), and translocates to the nucleus (36).  
Transfection of cells with a constitutively active MK2 construct induced 
stabilization of cytokine transcripts containing AREs (IL-6 and IL-8), while a 
dominant negative MK2 construct interfered with p38 MAPK-mediated mRNA 
stabilization (37).  Recent work calls into question whether p38/MK2 operates in 
series or in parallel with HuR.  With an elegant series of experiments, they have 
identified two distinct domains within the ARE of IL-8, both of which are 
necessary for mRNA destabilization in a quiescent cell.  HuR and MK2 bind 
separately to each domain.  HuR binds to an auxiliary domain within the IL-8 
ARE which causes modest mRNA stabilization.  HuR binding to the auxiliary 
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domain, however, increases the affinity of MK2 binding to the core domain of the 
IL-8 ARE.  MK2 binding to the core domain leads to further mRNA stabilization 
by inhibiting deadenylation of the 3’ tail of the IL-8 transcript (38).  These data 
suggest that MK2 and HuR operate in parallel and not in series as we propose.  
This does not necessarily contradict our model.  Firstly, the study only examines 
IL-8’s transcript.  While the same mechanism may apply to IFN-γ, it has not yet 
been confirmed.  Secondly, we only examine HuR translocation after 
manipulating MKK3.  While we conclude from this data that MKK3 is required for 
HuR translocation, and therefore infer that it acts via its substrate, p38 MAPK, we 
also established that either MKK3 or a signaling protein proximal to MKK3 must 
activate a protein in addition to p38 MAPK to achieve HuR translocation.  It is 
conceivable that the other protein (or proteins) activated by MKK3 are 
responsible for HuR translocation, and that the coordinated action of HuR and 
p38/MK2 are required for mRNA stabilization. 
The next step beyond discovering the pathway transducing LFA-1 
engagement-mediated mRNA stabilization is defining the significance of this 
mRNA stabilization to proper immune function in vivo.  T cells in general, and T 
cell LFA-1 activation specifically, have been implicated in numerous 
immune/inflammatory diseases.  The role of LFA-1 in rheumatoid arthiritis has 
been known for some time (39).  The inflammatory infiltrate within the synovium 
of joints in patients suffering from rheumatoid arthritis is rich with T cells, and it 
has been shown that LFA-1 engagement by endothelial ligands plays an integral 
role in development of the infiltrate.  Whether LFA-1 engagement mediates 
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proinflammatory signaling responsible for the development of rheumatoid arthritis 
through mRNA stabilization has not been investigated. 
Within the context of vascular biology, T cells play a vital role in vascular 
pathology such as atherosclerosis, chronic vascular rejection, and angioplasty 
restenosis.  Among the characteristics shared by the various forms of vascular 
pathology is endothelial dysfunction and injury.  This endothelial injury leads to 
alterations in the endothelial cell’s gene expression profile, including the up-
regulation of cell adhesion molecules used for leukocyte adhesion.  In a study 
examining atherosclerotic plaques, the intimal neovasculature within the plaque 
displayed significantly elevated levels of E-selectin, ICAM-1, and VCAM-1 
expression when compared to normal arterial luminal endothelium.  The 
increased expression of these adhesion molecules was strongly associated with 
intimal accumulation of leukocytes, particularly T cells (40).  Chronic graft 
rejection has also been established as primarily a vascular phenomenon 
mediated by T cell invasion into the vasculature, causing dense intimal fibrosis 
that is not unlike the mechanism of post-injury restenosis.  Furthermore, inhibition 
of the CD28 and CD40 signaling pathways within T cells has shown great 
promise in attenuating chronic graft rejection in rodents (41).  Percutaneous 
transluminal coronary angioplasty (PTCA) has been shown to increase the 
concentration of CD4+, IFN-γ expressing T cells.  This increase in T cell density 
can be attenuated by treating patients with statins following PTCA, which have 
been shown to interfere with T cell signaling (42).   Taken together, these data 
suggest that atherosclerosis, chronic graft rejection, and angioplasty restenosis 
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are all forms of vascular pathology that share the mechanism of T cell adhesion 
to injured vascular endothelium, followed by subintimal invasion with subsequent 
neointimal proliferation and fibrosis. 
The T cell integrin LFA-1 has been implicated in T cell adhesion to 
endothelium and the subsequent development of atherosclerosis (43).  In fact, 
oxidized low density lipoprotein (LDL), long known to be an important contributing 
factor for atherosclerosis, has been shown to be a potent trigger for LFA-1 
activation and subsequent leukocyte adhesion and transmigration into 
atherosclerotic plaques (44).  Angioplasty restenosis shares many mechanisms 
of pathogenesis with atherosclerosis.  PTCA with additional stent implantation is 
associated with a local recruitment of LFA-1 positive lymphocytes to the site of 
the procedure (45).  Furthermore, studies in Germany show that assessing the 
expression of LFA-1, and the monocyte counterpart Mac-1, in patients prior to 
angioplasty may predict the subsequent development of angioplasty restenosis 
(46). 
While T cells, acting through LFA-1 engagement by endothelial ICAM-1, 
have been implicated in vascular pathology, the role of signaling events 
downstream of LFA-1 engagement in vascular pathology have not been 
examined.  We aim to determine whether LFA-1 mediated mRNA stabilization of 
pro-inflammatory cytokine transcripts is an important step in the development of 
vascular pathology.  Preliminary data suggest that MKK3 deficient mice reject 
HY-mismatched skin grafts over a longer time course than their wild type 
counterparts (Figure 14).  An HY-mismatch model refers to a syngeneic skin graft 
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taken from a male donor and grafted onto a female recipient.  A protein encoded 
on the Y chromosome of the male donor graft (the HY protein) generates a minor 
histocompatability mismatch within the female recipient, causing a chronic graft 
rejection (47), but not one that requires immunosupression for graft viability.  In 
our preliminary experiments, the MKK3 knockout mice take an average of 7 days 
longer to reject HY-mismatched skin grafts than wild type BL/6 mice (data not 
shown as statistical significance was not reached).  We also have the HY-
mismatch model in place for aorta allograft experiments.  In both wild type and 
MKK3 knockout mice populations, sections of thoracic aorta are taken from a 
male donor and grafted onto a female recipient abdominal aorta.  Again, the 
donor HY antigen induces a recipient T cell response and chronic graft rejection.  
Because the graft is vascular, rejection will more closely approximate vascular 
pathology than skin graft rejection. 
It is important to note that MKK3 gene deleted mice are deficient in IL-12 
production.  IL-12 is a heterodimeric cytokine that plays an integral role in 
differentiating naïve CD4+ T cells into Th1 cells by inducing IFN-γ production 
(28).  The deficiency in IL-12 production in MKK3 knockout mice does not affect 
our presented in vitro results since our experiments focus on naïve T cells or T 
cell lines and therefore do not require IL-12.  The IL-12 defect is important, 
however, in discussing the extension of these experiments to an in vivo system, 
particularly when using a graft rejection model.  As stated, graft rejection is 
primarily a T cell-mediated phenomenon.  Specifically, a cell-mediated, Th1 
phenotype for CD4+ T cells is perhaps the most important component for 
 36
vascular rejection (1).  Without IL-12 production capabilities, MKK3 deficient 
naïve T cells are not capable of differentiating into a Th1 phenotype.  Therefore, 
it would be impossible to determine whether delayed graft rejection was truly a 
result of impaired mRNA stabilization of pro-inflammatory cytokine transcripts 
upon naïve T cell integrin engagement, or whether the delayed rejection is a 
result of the mouse’s inability to generate Th1 cells. 
As a solution, our lab is in the process of generating a conditional, “floxed” 
HuR knockout mouse.  When crossing the HuR-floxed mouse with a T cell-
specific (lck-promoter) cre recombinase transgenic mouse, a T cell HuR 
knockout mouse will be generated.  If the mouse has a normal repertoire of T 
cells, we will be able to identify the role of HuR in some of the T cell, in vivo 
models.  Knocking out T cell HuR would not only more definitively show that HuR 
is responsible for integrin engagement-mediated mRNA stabilization, it would 
allow us to further define the nature of HuR’s association with relevant mRNAs.  
These recombinant tools of genetic manipulation would give us the power to 
more precisely interrogate the role of HuR in T cell integrin engagement-
mediated mRNA stabilization, as well as the effects of this mRNA stabilization 
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Figure 1: The effect of purification on T cell concentration of murine 
splenocytes.  Murine splenocytes were isolated and purified as described in the 
Methods section.  A sample of splenocytes was taken after purification.  The 
samples were analyzed by flow cytometry using an antibody against the T cell-
specific protein CD3 conjugated to the fluorescent marker FITC, as well as an 
antibody against the NK cell-specific protein NK1.1 conjugated to the fluorescent 
marker PE. 
CD3 FITC only NK1.1 PE only CD3 FITC + NK1.1 PE





























































Figure 2: The effect of LFA-1 engagement on IFN-γ mRNA stabilization in 
murine T cells.  Mouse splenic T-cells were isolated as described, then 
immunostimulated with either PMA or PMA plus ICAM for 3 hr, after which the 
transcriptional inhibitor DRB was added (time 0).  The RNA was harvested at 
time 0 as well as at the indicated times for quantitative, real time RT-PCR using 
probes complementary to IFN-γ.  In this and all future mRNA stabilization 
experiments, IFN-γ mRNA levels were normalized against the stable transcript 






























































Figure 3: The effect of LFA-1 engagement on HuR nuclear-to-cytoplasmic 
translocation in murine T cells.  T cells were isolated from C57BL/6 mouse 
spleens and resuspended in LFA-1 activation buffer (2 mM MnCl2), following 
which they were plated on coverslips coated with 2.5 µg/ml murine Intercellular 
Adhesion Molecule-1 (ICAM-1) or poly-L-lysine for 15, 30, 45 and 60 minutes.  
Immunofluorescent analysis was performed with anti-HuR mAb (red) and the 
nuclear marker DAPI (blue).  Magnification 100X. 










Figure 4: The effect of HuR knockdown on Rac-1-mediated mRNA 
stabilization of ARE-containing transcripts in immortalized human T cells.  
Jurkat T cells were transfected with a rabbit β-globin construct containing the 3’-
UTR of uPAR, as well as chloramphenicol acetyl transferase to normalize 
transfection levels.  The T cells were also transfected with a constitutively active 
Rac-1 construct (Rac1 V12, Panel A), or a constitutively active Rac-2 construct 
(Rac2 L61, Panel B).  The cells were then split into two populations, with half 
receiving a double-stranded RNA interference sequence specific for HuR 
(HuRsiRNA) while the other half received a scrambled double stranded RNA 
sequence (ScRNA).  RNA interference succeeded in knocking HuR down by at 
least 80% compared to baseline levels (top panels).  AUF-1 was used to 
normalize protein levels.  The lower panels show the effect of knocking down 
HuR on Rac-1-mediated mRNA stabilization.  The T cells were stimulated by the 
addition of serum and, following the withdrawal of serum, were lysed at various 
time points and mRNA levels analyzed at each time point using quantitative, real 










































































































































Figure 5: The effect of LFA-1 engagement upon p38 MAPK and JNK 
activation in murine T cells.  Murine T cells were suspended in LFA-1 
activation buffer and plated on msICAM-1 coated dishes.  Adherent and 
nonadherent cells were collected and lysed at the noted time points. The cell 
lysates were assayed for total and phosphorylated protein by Western blot 
analysis. Panel A shows p38 MAPK activity following LFA-1 engagement by 
msICAM-1.  Phosphorylated p38 MAPK was normalized to total p38 MAPK within 
the Western blot.  Panel B shows JNK activity.  C-jun is a substrate for JNK, and 
phosphorylated c-jun is the customary readout for JNK activity, which was 















































































Figure 6: The effect of JNK activity upon LFA-1 engagement-mediated 
mRNA stabilization in murine T cells.  Panel A illustrates a sample dose 
response curve for SP600125, a JNK-specific pharmacologic inhibitor.  Murine T 
cells were suspended in LFA-1 activation buffer and plated on msICAM-1 coated 
dishes with varying concentrations of SP600125.  Adherent and nonadherent 
cells were collected and lysed at the noted time points.  JNK activity was 
quantitated by normalizing phospho-c-jun against total JNK by Western blot 
analysis.  Panels B & C: Murine T cells were stimulated for 3 hours with PMA, 
PMA and ICAM-1 or PMA, ICAM-1 and SP600125.  Panel B: immediately 
following stimulation, the cells were lysed and their mRNA quantitated via 
quantitative, real time RT-PCR using primers for IFN-γ.  Panel C: Transcription 
was inhibited following stimulation.  RNA was harvested at the time of 
transcriptional arrest as well as the indicated time points and the mRNA 













































































































































Figure 7: Effect of JNK inhibition on LFA-1 engagement-mediated HuR 
translocation in murine T cells.  T cells were isolated from C57BL/6 mouse 
spleens, resuspended in LFA-1 activation buffer containing vehicle or the two 
noted doses of SP600125, and plated on coverslips coated with murine ICAM-1 
or poly-L-lysine for 60 minutes.  Immunofluorescent analysis was performed with 





















Figure 8: The effect of p38 MAPK activity on mRNA stabilization in murine T 
cells.  Panel A illustrates a sample dose response curve for SB203580, a p38 
MAPK-specific pharmacologic inhibitor.  Murine T cells were suspended in LFA-1 
activation buffer and plated on msICAM-1 coated dishes with varying 
concentrations of SB203580.  Adherent and nonadherent cells were collected 
and lysed at the noted time points.  P38 MAPK activity was quantitated by 
normalizing phospho-p38 MAPK against total p38 MAPK by Western blot 
analysis.  Panels B & C: Murine T cells were stimulated with PMA, PMA and 
ICAM-1 or PMA, ICAM-1 and SB203580.  Panel B: immediately following 
stimulation, the cells were lysed and their mRNA quantitated via quantitative, real 
time RT-PCR using primers for IFN-γ.  Panel C: Transcription was inhibited 
following stimulation.  RNA was harvested at the time of transcriptional arrest as 
well as the indicated time points and the mRNA quantitated via quantitative, real 













































































































































Figure 9: The effect of MKK3 gene deletion upon p38 MAPK and JNK 
expression in murine T cells.  Murine splenic T cells were suspended in LFA-1 
activation buffer and plated on msICAM-1 coated dishes.  Adherent and 
nonadherent cells were collected and lysed after 1 hour.  p38 MAPK activity (A) 
and JNK activity (B) were assessed via Western blot analysis.  Activity was 
measured as a function of the phosphorylated enzyme (A) or its substrate (B) 
normalized against the total concentration of the MAPK.  Data are presented as 































































































































Figure 10: The effect of MKK3 gene deletion upon interferon gamma mRNA 
levels in murine T cells.  Murine splenic T cells were isolated from MKK3+/+, 
MKK3+/-, and MKK3-/- mice and stimulated with PMA and ICAM for 3 hours.  
After stimulation, the T cells were lysed and IFN-g mRNA levels were quantitated 
via quantitative, real time RT-PCR using primers complementary for IFN-γ.  IFN-γ 
mRNA levels were normalized against IFN-γ mRNA levels in MKK3+/+ T cells 














































































Figure 11: The effect of MKK3 gene deletion upon LFA-1 engagement-
mediated mRNA stabilization of interferon gamma transcripts in murine T 
cells.  Murine splenic T cells were isolated from MKK3+/+, MKK3+/-, and MKK3-
/- mouse splenocytes and stimulated with PMA and ICAM for 3 hours.  After 
stimulation, transcription was inhibited by the addition of DRB.    At the time of 
transcriptional arrest as well as the indicated time points after addition of DRB, T 
cells were lysed, mRNA harvested, and IFN-γ levels analyzed via quantitative, 



























































Figure 12: The effect of MKK3 gene deletion upon HuR nuclear-to-
cytoplasmic translocation in murine T cells.  T cells were isolated from 
MKK3+/+, MKK3+/-, and MKK3-/- mouse spleens.  The cells were then treated 
with LFA-1 activation buffer and plated on ICAM-1 coated coverslips for 60 
minutes.  Immunofluorescent analysis was performed with anti-HuR mAb (red) 
and the nuclear marker DAPI (blue).  Magnification 100X. 




















































Figure 14: The effect of MKK3 gene deletion upon rejection of skin grafts in 
mice.  Preliminary pictures of skin grafts taken from wild type and MKK3-/- 
C57BL/6 male donors and grafted onto wild type and MKK3-/- C57BL/6 female 
recipients, respectively.  The pictures are taken at 14 and 28 days after graft 
transplant.  Rejection of the graft causes contraction of the transplanted skin.  
Therefore, a larger area of transplanted tissue indicates a greater amount of 
viable graft remaining on the recipient.  We define rejection at 100% contraction 
of the graft (when the recipient’s skin has completely grown over the graft site, 
such as MKK3+/+ at 28 days). 
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